2021年9月
Longitudinal observation of insulin secretory ability before and after the onset of immune checkpoint inhibitor-induced diabetes mellitus: A report of two cases.
Clinical case reports
- ,
- ,
- ,
- ,
- ,
- ,
- ,
- 巻
- 9
- 号
- 9
- 開始ページ
- e04574
- 終了ページ
- 記述言語
- 英語
- 掲載種別
- DOI
- 10.1002/ccr3.4574
Immune checkpoint inhibitor-induced diabetes mellitus is a rare immune-related adverse event. This report illustrates clinical data and insulin secretory ability before and after the onset of immune checkpoint inhibitor-induced diabetes.
- リンク情報
- ID情報
-
- DOI : 10.1002/ccr3.4574
- PubMed ID : 34522382
- PubMed Central 記事ID : PMC8424178